PathNova Laboratories
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PathNova Laboratories - overview
Established
2017
Location
Singapore, -, Singapore
Primary Industry
Healthcare Specialists
About
Founded in 2017 and based in Singapore, Pathnova Laboratories Pte. Ltd. , dba PathNova Laboratories is a healthcare service provider that uses machine learning to scale nasopharyngeal cancer detection. The company is spun out of Temasek Life Sciences Laboratory in 2017.
The company is focused on enabling the scalable detection of nasopharyngeal cancer (NPC) and autoimmune disease by developing an AI framework. The firm aims to solve this cancer by automating the IFA using pattern recognition to simultaneously detect and quantitate NPC disease load for clear-cut cases.
Current Investors
Temasek Life Sciences Accelerator, SEEDS Capital, Todos Medical Ltd.
Primary Industry
Healthcare Specialists
Sub Industries
Oncology/Cancer Treatment
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
PathNova Laboratories - timeline of key events
PathNova Laboratories - financials
| Fiscal Year Ended | Apr 30, 2018 | Apr 30, 2019 | Apr 30, 2020 | Apr 30, 2021 | Apr 30, 2022 | Apr 30, 2023 | Apr 30, 2024 | Apr 30, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 328 | - | 5,438 | 2,181,924 | 12,020,208 | - | - | - |
| % Revenue Growth (YoY) | - | (100.0%) | - | 40023.6% | 450.9% | - | - | - |
| EBITDA (USD) | (372,568) | (381,471) | (326,162) | 758,075 | 5,616,010 | - | - | - |
| Operating Income (USD) | (508,505) | (419,164) | (364,897) | 703,930 | 5,312,775 | - | - | - |
| Operating Margin | (155032.0%) | - | (6710.1%) | 32.3% | 44.2% | - | - | - |
| % EBITDA Margin | (113587.8%) | - | (5997.8%) | 34.7% | 46.7% | - | - | - |
| NET Income (USD) | (508,505) | (419,164) | (364,895) | 703,930 | 4,457,637 | - | - | - |
| % Net Margin | (155032.0%) | - | (6710.1%) | 32.3% | 37.1% | - | - | - |
PathNova Laboratories - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.